Literature DB >> 23731843

Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.

Fabia Attili1, Gabriele Capurso2, Giuseppe Vanella1, Lorenzo Fuccio3, Gianfranco Delle Fave2, Guido Costamagna1, Alberto Larghi4.   

Abstract

Gastroenteropancreatic neuroendocrine neoplasms have substantially increased over the last decades. Because of the indolent clinical course of the disease even in advance stages and the rise in the incidental diagnosis of small asymptomatic lesions, the prevalence of gastroenteropancreatic neuroendocrine neoplasms is higher than that of pancreatic, gastric and oesophageal adenocarcinomas, making them the second most prevalent cancer type of the gastrointestinal tract. This increase in the overall prevalence of gastroenteropancreatic neuroendocrine neoplasms has been paralleled by a growth in the importance of the endoscopist in the care of these patients, who usually require a multidisciplinary approach. In this manuscript the diagnostic and therapeutic role of endoscopic for gastroenteropancreatic neuroendocrine neoplasms will be reviewed.
Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Endoscopic ultrasound; Endoscopy; Gastroenteropancreatic neuroendocrine neoplasms; Therapy

Mesh:

Year:  2013        PMID: 23731843     DOI: 10.1016/j.dld.2013.04.007

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  5 in total

1.  Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study.

Authors:  Angela Spanu; Orazio Schillaci; Bastiana Piras; Diego F Calvisi; Antonio Falchi; Roberta Danieli; Susanna Nuvoli; Franca Dore; Giuseppe Madeddu
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

2.  Grading of EUS-FNA cytologic specimens from patients with pancreatic neuroendocrine neoplasms: it is time move to tissue core biopsy?

Authors:  Rakesh Vinayek; Gabriele Capurso; Alberto Larghi
Journal:  Gland Surg       Date:  2014-11

3.  Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?

Authors:  D Mark Pritchard; Christos Toumpanakis; Klaire Exarchou; Lukasz Kamieniarz; Marina Tsoli; Alexandra Victor; Kira Oleinikov; Mohid S Khan; Raj Srirajaskanthan; Dalvinder Mandair; Simona Grozinsky-Glasberg; Gregory Kaltsas; Nathan Howes
Journal:  Endocrine       Date:  2021-06-12       Impact factor: 3.633

4.  Endoscopic ultrasound-guided fine-needle biopsy is superior to fine-needle aspiration in assessing pancreatic neuroendocrine tumors.

Authors:  John S Leeds; Manu K Nayar; Noor L H Bekkali; Colin H Wilson; Sarah J Johnson; Beate Haugk; Antony Darne; Kofi W Oppong
Journal:  Endosc Int Open       Date:  2019-10-01

5.  Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms.

Authors:  Susumu Hijioka; Kazuo Hara; Nobumasa Mizuno; Hiroshi Imaoka; Vikram Bhatia; Mohamed A Mekky; Kenichi Yoshimura; Tsukasa Yoshida; Nozomi Okuno; Nobuhiro Hieda; Masahiro Tajika; Tsutomu Tanaka; Makoto Ishihara; Yasushi Yatabe; Yasuhiro Shimizu; Yasumasa Niwa; Kenji Yamao
Journal:  J Gastroenterol       Date:  2016-01-14       Impact factor: 7.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.